This is a joint webinar AFFECT-EU and EHRA.
Due to demographic changes, we are facing an arrhythmia epidemic projected to double by 2050. AF is often asymptomatic, with its first manifestation being a debilitating stroke in 11.5% of patients. Arrhythmia produces high healthcare costs for European society, precluding healthy ageing, and its detection may be challenging. Since population-based systematic screening may not work across healthcare systems, enrichment techniques like biomarkers, imaging, and artificial intelligence-based ECG interpretation may be applied.
There is a surge of new devices/wearables, some producing an ECG and others only detecting arrhythmias. However, information on their validity and experience in practical use is limited. In order to establish a link to care pathways in the virtual world, all these issues – including gaps in knowledge – related to new rhythm-monitoring technologies and novel strategies will be discussed at our webinar based on current evidence and guideline recommendations.
Learning objectives
After watching this webinar, participants will have up-to-date knowledge on:
- application and validity of new technologies for rhythm monitoring;
- digital applications and decision-support tools;
- consumer-facing technologies, patient-led rhythm monitoring;
- (missing) linkage to care pathways in the virtual world;
- current AF screening practice reality and ongoing studies;
- selection of the optimal target population for screening;
- relevance of refined screening, prediction of risk factors and comorbidities;
- mode, intensity and length of screening for AF detection;
- European stakeholder perspectives on AF screening implementation; and
- patient education on risks/benefits of new technologies
Needs assessment and expected educational outcome
To establish a link to virtual world rhythm-monitoring technologies involving new devices and wearables that can detect abnormal heart rhythms indicative of asymptomatic arrhythmias that can be harbingers of heart failure and stroke.
